These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22117997)

  • 1. Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values.
    Saigo K; Takenokuchi M; Hiramatsu Y; Tada H; Hishita T; Takata M; Misawa M; Imoto S; Imashuku S
    J Int Med Res; 2011; 39(5):1941-5. PubMed ID: 22117997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ferritin levels of the serum and red blood cells in patients with myelodysplastic syndrome (MDS)].
    Sakurada K; Miyazaki T
    Rinsho Ketsueki; 1986 Sep; 27(9):1789-95. PubMed ID: 3806987
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative stress and mitochondrial dysfunction play a role in myelodysplastic syndrome development, diagnosis, and prognosis: A pilot study.
    Gonçalves AC; Cortesão E; Oliveiros B; Alves V; Espadana AI; Rito L; Magalhães E; Lobão MJ; Pereira A; Nascimento Costa JM; Mota-Vieira L; Sarmento-Ribeiro AB
    Free Radic Res; 2015; 49(9):1081-94. PubMed ID: 25968944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.
    Kikuchi S; Kobune M; Iyama S; Sato T; Murase K; Kawano Y; Takada K; Ono K; Kaneko Y; Miyanishi K; Sato Y; Hayashi T; Takimoto R; Kato J
    Free Radic Biol Med; 2012 Aug; 53(4):643-8. PubMed ID: 22705364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell folate in elderly patients with myelodysplastic syndrome.
    Cafolla A; Dragoni F; Girelli G; Tosti ME; Monarca B; Kendall R; Scott CS
    Eur J Haematol; 1998 Sep; 61(3):160-3. PubMed ID: 9753411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
    Kim IH; Moon JH; Lim SN; Sohn SK; Kim HG; Lee GW; Kim YS; Lee HS; Kwon KY; Kim SH; Park KT; Chung JS; Lee WS; Lee SM; Hyun MS; Kim H; Ryoo HM; Bae SH; Joo YD
    Transfusion; 2015 Jul; 55(7):1613-20. PubMed ID: 25764017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
    Zhang Y; Xiao C; Gu SC; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome.
    Ghoti H; Amer J; Winder A; Rachmilewitz E; Fibach E
    Eur J Haematol; 2007 Dec; 79(6):463-7. PubMed ID: 17976187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome.
    List AF; Baer MR; Steensma DP; Raza A; Esposito J; Martinez-Lopez N; Paley C; Feigert J; Besa E
    J Clin Oncol; 2012 Jun; 30(17):2134-9. PubMed ID: 22547607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Simultaneous Elevation of Oxidative Stress Markers and Wilms' Tumor 1 Gene during the Progression of Myelodysplastic Syndrome.
    Shimizu N; Hasunuma H; Watanabe Y; Matsuzawa Y; Iwashita Y; Tatsuno I; Yokota H
    Intern Med; 2016; 55(24):3661-3664. PubMed ID: 27980269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].
    Qin Y; Liu H; Ruan S; Cai YF; You XF; Song GQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):758-61. PubMed ID: 22339912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M; Uchiyama T; Okamoto S; Kanakura Y; Sawada K; Tomonaga M; Nakao S; Nakahata T; Harada M; Murate T; Ozawa K;
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency.
    Murphy PT; Quinn JP; O'Donghaile D; Swords R; O'Donnell JR
    Ann Hematol; 2006 Jul; 85(7):455-7. PubMed ID: 16568320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications.
    Remacha ÁF; Arrizabalaga B; Villegas A; Durán MS; Hermosín L; de Paz R; Garcia M; Diez Campelo M; Sanz G;
    Ann Hematol; 2015 May; 94(5):779-87. PubMed ID: 25516455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In myelodysplastic syndrome cases, what should be the level of ferritin which has prognostic value?
    Senturk Yikilmaz A; Akinci S; Bakanay ŞM; Dilek I
    Transfus Clin Biol; 2019 Nov; 26(4):217-223. PubMed ID: 31420221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of haemoglobin in patients presenting to their general practitioner, and its correlation with serum ferritin.
    Challand GS; Michaeloudis A; Watfa RR; Coles SJ; Macklin JL
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():15-20. PubMed ID: 2310152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.